Melanoma development and progression: a conspiracy between tumor and host.

While a genome-centric paradigm in human cancer development was useful for the understanding of some malignancies such as leukemias, causative molecular defects intrinsic to melanocytes have not been defined in the majority of human melanomas. Recent work, however, has shown that regulatory signals governing melanocytic cell growth and differentiation may originate from the surrounding host cells either directly through physical contact or indirectly through soluble factors and extracellular matrix molecules. In this review, we present experimental systems useful for dissecting melanoma-host interactions and highlight evidence that the tumor microenvironment contributes to the oncogenic process. Thus, melanomagenesis is not merely an act of a single outlaw but a conspiracy orchestrated by multiple partners in the neighborhood who come into play in a precise spatiotemporal order. Defining intercellular molecular dialogues in human skin promises to provide key information for the development of novel treatment strategies that target the functional unit of stroma and tumor.

[1]  A. Cochran,et al.  Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen types IV and VII , 2000, Melanoma research.

[2]  D. Elder,et al.  Melanoma-stroma interactions: structural and functional aspects. , 2002, The Lancet. Oncology.

[3]  K Satyamoorthy,et al.  N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. , 2001, Cancer research.

[4]  C. Heldin,et al.  Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Elder,et al.  Progression-related expression of beta3 integrin in melanomas and nevi. , 1999, Human pathology.

[6]  W. Clark,et al.  Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. , 1989, Cancer research.

[7]  Y. Gall,et al.  Studies on epidermis reconstructed with and without melanocytes: melanocytes prevent sunburn cell formation but not appearance of DNA damaged cells in fair-skinned caucasians. , 2000, The Journal of investigative dermatology.

[8]  M. Herlyn,et al.  Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development , 2001, Oncogene.

[9]  C. Berking,et al.  Fibroblast growth factor‐2 but not Mel‐CAM and/or β3 integrin promotes progression of melanocytes to melanoma , 2003, Experimental dermatology.

[10]  A. P. Soler,et al.  Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin , 1995, The Journal of cell biology.

[11]  J. Becker,et al.  Coexpression of Integrin αvβ3 and Matrix Metalloproteinase-2 (MMP-2) Coincides with MMP-2 Activation: Correlation with Melanoma Progression , 2000 .

[12]  M. Greene,et al.  Dysplastic nevus syndrome. Familial and sporadic precursors of cutaneous melanoma. , 1985, Dermatologic clinics.

[13]  Y. Tokura,et al.  Interleukin‐10 expressed at early tumour sites induces subsequent generation of CD4+ T‐regulatory cells and systemic collapse of antitumour immunity , 2001, Immunology.

[14]  M. Herlyn,et al.  Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture. , 1987, Cancer research.

[15]  C. Morimoto,et al.  Beta 1 integrin-mediated signaling in human T cells. , 1996, Human Cell.

[16]  B. Janji,et al.  Autocrine TGF‐β‐regulated expression of adhesion receptors and integrin‐linked kinase in HT‐144 melanoma cells correlates with their metastatic phenotype , 1999, International journal of cancer.

[17]  R. Halaban,et al.  Growth factors and melanomas. , 1996, Seminars in oncology.

[18]  L. Liotta,et al.  The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. , 1989, The Journal of biological chemistry.

[19]  M. Herlyn,et al.  Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. , 2000, Journal of cell science.

[20]  P. Brown Clinical studies with matrix metalloproteinase inhibitors , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[21]  A. Le Bivic,et al.  Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. , 2001, Blood.

[22]  N. Hacker,et al.  Anti–sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell–adhesion and tumorigenicity in ovarian cancer cells , 2000, International journal of cancer.

[23]  I. Shih,et al.  Interactions of melanocytes and melanoma cells with the microenvironment. , 1994, Pigment cell research.

[24]  T. Faraggiana,et al.  Transforming growth factor‐β enhances adhesion of melanoma cells to the endothelium in vitro , 1997, International journal of cancer.

[25]  A. Chiba Precision Networking A Look through the Eyes of a Fly , 2001, Neuron.

[26]  Jeffrey W. Smith,et al.  Functional activation of integrin αvβ3 in tumor cells expressing membrane‐type 1 matrix metalloproteinase , 2000 .

[27]  M. Bar‐eli Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma , 1999, Pathobiology.

[28]  M. Herlyn,et al.  Insulin-like Growth Factor-1 Induces Survival and Growth of Biologically Early Melanoma Cells through Both the Mitogen-activated Protein Kinase and β-Catenin Pathways , 2001 .

[29]  D. Elder,et al.  Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. , 1993, The American journal of pathology.

[30]  M. Biggs,et al.  Suppression of immune surveillance in melanoma. , 2001, Medical hypotheses.

[31]  Thomas B. Fitzpatrick,et al.  Dermatology in general medicine , 1971 .

[32]  L. Chin,et al.  Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. , 1997, Genes & development.

[33]  A. Taïeb,et al.  Ex vivo study of skin phototypes. , 1996, The Journal of investigative dermatology.

[34]  L. Chin,et al.  Induction of melanoma in murine macrophage inflammatory protein 2 transgenic mice heterozygous for inhibitor of kinase/alternate reading frame. , 2001, Cancer research.

[35]  P. Morin,et al.  β‐catenin signaling and cancer , 1999 .

[36]  L. Chin,et al.  Animal models of melanoma: recent advances and future prospects. , 2000, Advances in cancer research.

[37]  S. Rafii,et al.  Circulating endothelial precursors: mystery, reality, and promise. , 2000, The Journal of clinical investigation.

[38]  L. Chin,et al.  Murine models of malignant melanoma. , 2000, Molecular medicine today.

[39]  D. Ruiter,et al.  Matrix metalloproteinases in human melanoma. , 2000, The Journal of investigative dermatology.

[40]  M. Eisinger,et al.  Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Tuan,et al.  Wnt regulation of limb mesenchymal chondrogenesis is accompanied by altered N‐cadherin‐related functions , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  P. Nowell,et al.  Cytogenetics of human malignant melanoma and premalignant lesions. , 1984, Cancer genetics and cytogenetics.

[43]  M. Iruela-Arispe,et al.  Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF‐β1 , 1993, Journal of cellular biochemistry.

[44]  J. Becker,et al.  Differential expression of transforming growth factor beta 1 and interleukin 10 in progressing and regressing areas of primary melanoma. , 1999, Journal of experimental & clinical cancer research : CR.

[45]  S. Toda,et al.  Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. , 2001, Biochemical and biophysical research communications.

[46]  J. Johnson,et al.  MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. , 1997, Journal of immunology.

[47]  I. Shih,et al.  Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. , 1997, Cancer research.

[48]  R. Ruch The role of gap junctional intercellular communication in neoplasia. , 1994, Annals of clinical and laboratory science.

[49]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[50]  P. Gariglio,et al.  Interleukin‐10 promotes B16‐melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation , 2002, Immunology.

[51]  D. Elder,et al.  UVB induces atypical melanocytic lesions and melanoma in human skin. , 1998, The American journal of pathology.

[52]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[53]  D. Elder,et al.  Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. , 1994, The American journal of pathology.

[54]  J. Sampol,et al.  S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. , 1996, Tissue antigens.

[55]  M. Herlyn,et al.  Shifts in cadherin profiles between human normal melanocytes and melanomas. , 1996, The journal of investigative dermatology. Symposium proceedings.

[56]  B. Gumbiner,et al.  Adhesion signaling: How β-catenin interacts with its partners , 2001, Current Biology.

[57]  S. Rafii,et al.  Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.

[58]  K. Kinzler,et al.  Association of the APC tumor suppressor protein with catenins. , 1993, Science.

[59]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. Berking,et al.  Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. , 2001, The American journal of pathology.

[61]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[62]  M. Herlyn,et al.  Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors , 1987, International journal of cancer.

[63]  C. Berking,et al.  Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. , 2001, Cancer research.

[64]  B. Nielsen,et al.  Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[65]  B. Fingleton,et al.  Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  S. Tóth,et al.  Autocrine and paracrine regulation by cytokines and growth factors in melanoma. , 2000, Cytokine.

[67]  S. Kuroda,et al.  Cell adhesion and Rho small GTPases. , 1999, Journal of cell science.

[68]  K. Tanabe,et al.  Involvement of CD44 in matrix metalloproteinase‐2 regulation in human melanoma cells , 1999, International journal of cancer.

[69]  D. Hanahan,et al.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.

[70]  P. Polakis,et al.  The APC Protein and E-cadherin Form Similar but Independent Complexes with α-Catenin, β-Catenin, and Plakoglobin (*) , 1995, The Journal of Biological Chemistry.

[71]  J. Uitto,et al.  Specific sequences in p120ctn determine subcellular distribution of its multiple isoforms involved in cellular adhesion of normal and malignant epithelial cells. , 2002, Journal of cell science.

[72]  K. Syrigos,et al.  E‐cadherin/catenin complex in benign and malignant melanocytic lesions , 1998, The Journal of pathology.

[73]  S. De Flora,et al.  ‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  Paul S. Meltzer,et al.  Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[75]  I. Shih,et al.  Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[76]  D. Rimm,et al.  Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. , 1999, The American journal of pathology.

[77]  J. Taylor‐Papadimitriou,et al.  Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Anita B. Roberts,et al.  REGULATION OF IMMUNE RESPONSES BY TGF-β* , 1998 .

[79]  J. Johnson,et al.  MUC18: A cell adhesion molecule with a potential role in tumor growth and tumor cell dissemination. , 1996, Current topics in microbiology and immunology.

[80]  M. Herlyn,et al.  Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication , 2001, Oncogene.

[81]  A. Cress,et al.  Androgen induction of in vitro prostate cell differentiation. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[82]  J. Garlick,et al.  Normal keratinocytes suppress early stages of neoplastic progression in stratified epithelium. , 1998, Cancer research.

[83]  M. Stack,et al.  Intact Vitronectin Induces Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinases-2 Expression and Enhanced Cellular Invasion by Melanoma Cells* , 1998, The Journal of Biological Chemistry.

[84]  W. Clark,et al.  Biomarkers for individual susceptibility to carcinogenic agents: excretion and carcinogenic risk of benzo[a]pyrene metabolites. , 1992, Environmental health perspectives.

[85]  M. Mareel,et al.  The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness , 2001, The Journal of cell biology.

[86]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.

[87]  P. Brown Ongoing trials with matrix metalloproteinase inhibitors , 2000, Expert opinion on investigational drugs.

[88]  M. Herlyn,et al.  Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[89]  P. Duray,et al.  Neonatal sunburn and melanoma in mice , 2001, Nature.

[90]  K. Matsumoto,et al.  Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. , 1991, Biochemical and biophysical research communications.

[91]  T. Krieg,et al.  Tissue Inhibitor of Matrix Metalloproteinase-2 Regulates Matrix Metalloproteinase-2 Activation by Modulation of Membrane-type 1 Matrix Metalloproteinase Activity in High and Low Invasive Melanoma Cell Lines* , 1999, The Journal of Biological Chemistry.

[92]  Judith P. Johnson,et al.  Analysis of the expression of intercellular adhesion molecule‐1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non‐glycosylated antigen , 1997, Melanoma research.

[93]  Carola Berking,et al.  Human Xenografts, Human Skin and Skin Reconstructs for Studies in Melanoma Development and Progression , 2004, Cancer and Metastasis Reviews.

[94]  D. Elder,et al.  Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. , 1998, The American journal of pathology.

[95]  G. Ghanem,et al.  Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin , 2000, The British journal of dermatology.

[96]  D. Elder,et al.  E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. , 2000, The American journal of pathology.

[97]  W. Pawlak,et al.  Molecular biology of cutaneous melanoma , 2003 .

[98]  A. Bosserhoff,et al.  Loss of E-cadherin Expression in Melanoma Cells Involves Up-regulation of the Transcriptional Repressor Snail* , 2001, The Journal of Biological Chemistry.

[99]  S. Hirohashi,et al.  E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. , 1994, Journal of cell science.

[100]  C. Berking,et al.  Photocarcinogenesis in human adult skin grafts. , 2002, Carcinogenesis.

[101]  R. Halaban,et al.  met and HGF-SF in normal melanocytes and melanoma cells. , 1993, EXS.

[102]  Toshikazu Nakamura,et al.  Keratinocyte expression of transgenic hepatocyte growth factor affects melanocyte development, leading to dermal melanocytosis , 2000, Mechanisms of Development.

[103]  D. Elder,et al.  Human melanoma progression in skin reconstructs : biological significance of bFGF. , 2000, The American journal of pathology.

[104]  M. Herlyn,et al.  Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells1 , 2001, The Journal of Immunology.

[105]  É. Vivier,et al.  Activation of Human Endothelial Cells via S-Endo-1 Antigen (CD146) Stimulates the Tyrosine Phosphorylation of Focal Adhesion Kinase p125FAK * , 1998, The Journal of Biological Chemistry.

[106]  M. Sporn Chemoprevention of cancer. , 1993, Lancet.

[107]  Y. Mo,et al.  The novel catenin p120cas binds classical cadherins and induces an unusual morphological phenotype in NIH3T3 fibroblasts. , 1996, Experimental cell research.

[108]  K. Nishii,et al.  Diversity and molecular anatomy of gap junctions , 2001, Medical Electron Microscopy.

[109]  R. Sharp,et al.  c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. , 1998, Cancer research.

[110]  B. M. Mueller Different roles for plasminogen activators and metalloproteinases in melanoma metastasis. , 1996, Current topics in microbiology and immunology.

[111]  M. Farthing,et al.  The E‐cadherin/epidermal growth factor receptor interaction: a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation , 1999, The Journal of pathology.

[112]  P. Nowell,et al.  Karyotypic evolution in human malignant melanoma. , 1986, Cancer genetics and cytogenetics.

[113]  R L Juliano,et al.  Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. , 2002, Annual review of pharmacology and toxicology.

[114]  M. Herlyn,et al.  Dynamics of intercellular communication during melanoma development. , 2000, Molecular medicine today.

[115]  M. Hori,et al.  WNT/Frizzled-2 Signaling Induces Aggregation and Adhesion among Cardiac Myocytes by Increased Cadherin–β-Catenin Complex , 2000, The Journal of cell biology.

[116]  O. Larsson,et al.  Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target , 1998, Melanoma research.

[117]  E. Voura,et al.  Cell–cell interactions during transendothelial migration of tumor cells , 1998, Microscopy research and technique.

[118]  G. Scott,et al.  Rac1 mediates dendrite formation in response to melanocyte stimulating hormone and ultraviolet light in a murine melanoma model. , 1998, The Journal of investigative dermatology.

[119]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[120]  M. Herlyn,et al.  Phenotypes and interactions of human melanocytes and keratinocytes in an epidermal reconstruction model. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[121]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .